Schar expert Dr. Anne shares her perspective on a new study about the topic.
A recent article by Medical Daily summarized a study by the National Institute of Health in a double-blind placebo study testing 59 individuals who believe they have Non-Celiac Gluten Sensitivity. Individuals exposed to glutenous products experienced abdominal pain, a foggy mind, bloating, depression, and stomach ulcers, whereas those given a placebo experienced no side effects.
This is great news for those suffering from non-celiac gluten sensitivity. The results of this double blind placebo controlled study report a significant measurable increase in symptoms associated with blinded ingestion of gluten in individuals with suspected NCGS. This trial provides solid evidence of the existence of NCGS.
The Dr Schar Institute has been working with some of the world leaders in celiac disease research and this new unfolding area of gluten sensitivity. For more research updates and reviews please visit the Dr Schar Institute.